Generic Lyrica will likely not be available until at least December 2018. Until then, be aware that any medicine sold on the Internet claiming to be generic Lyrica may be fake, substandard, and potentially dangerous. Do not buy any generic Lyrica drug until an approved generic is available.
Lyrica is manufactured by Pfizer, Inc. Currently, Lyrica is protected by a patent that prevents any generic Lyrica from being manufactured. Yet, if you search the Internet for "generic Lyrica," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous. You should not buy any generic Lyrica until there is an approved generic available.
When Will There Be a Generic Lyrica?
The first patent for Lyrica expired in October 2013, yet no generic version is available. This is likely due to a court ruling that has upheld a December 2018 Lyrica patent, which means that Lyrica will likely not "go generic" until then.
However, there are other circumstances that could come up to extend the exclusivity period of Lyrica beyond 2018. These circumstances could include things such as lawsuits or other patents for specific Lyrica uses.
Is Pregabalin a Generic Lyrica?
No, it isn't. Pregabalin is the active ingredient in Lyrica, not a generic version of the drug. Oftentimes, the active ingredient of any drug is referred to as its "generic name." But the generic name of a medicine is different from a generic version of it. For there to be a generic version of a medicine, the original medicine must have gone off patent and another company (besides the original manufacturer) must have made the product.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Lyrica [package insert]. New York, NY: Pfizer Inc.;2012 June.
Drug Store News. Court rules in favor of Pfizer, Northwestern University in Lyrica patent case (7/24/2012). DSN Web site. Available at: http://drugstorenews.com/article/court-rules-favor-pfizer-northwestern-university-lyrica-patent-case. Accessed July 27, 2012.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed December 3, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click